An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential-Reference-Cited by-同舟云学术

An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential

Published:2015-11 Issue:11 Volume:26 Page:1056-1063
ISSN:0955-3959
Container-title:International Journal of Drug Policy
language:en
Short-container-title:International Journal of Drug Policy

Author:

Perlman David C.,Jordan Ashly E.,Uuskula Anneli,Huong Duong Thi,Masson Carmen L.,Schackman Bruce R.,Des Jarlais Don C.

Funder

National Institute of Health

Publisher

Elsevier BV

Subject

Health Policy,Medicine (miscellaneous)

Reference129 articles.

1. Knowledge of HIV serostatus and risk behaviour among injecting drug users in Estonia;Abel-Ollo;AIDS Care,2009

2. Global estimates of prevalence of HCV infection among injecting drug users;Aceijas;International Journal of Drug Policy,2007

3. Act on Narcotic drugs and psychotropic substances and precursors thereof. Retrieved from https://www.riigiteataja.ee/en/eli/530102013024/consolide.

4. Stigma, discrimination and the health of illicit drug users;Ahern;Drug and Alcohol Dependence,2007

5. Recovery, persistance, and sequelae in hepatitis C virus infection: A perspective on long-term outcome;Alter;Seminars in Liver Diseases,2000

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “The machine doesn't judge”: Counternarratives on surveillance among people accessing a safer opioid supply via biometric machines;Social Science & Medicine;2024-03

2. Reducing Liver Cancer Risk through Dietary Change: Positive Results from a Community-Based Educational Initiative in Three Racial/Ethnic Groups;Nutrients;2022-11-18

3. “That was quick, simple, and easy”: Patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prison;International Journal of Drug Policy;2022-01

4. Client resistance to hepatitis C treatment initiation in opioid agonist treatment clinics in Sydney, Australia: A qualitative study;Drug and Alcohol Review;2021-11-28

5. New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years;World Journal of Gastroenterology;2021-08-07